Bronsema Kees J, Bischoff Rainer, van de Merbel Nico C
Analytical Biochemistry, Department of Pharmacy, University of Groningen , A. Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Anal Chem. 2013 Oct 15;85(20):9528-35. doi: 10.1021/ac4015116. Epub 2013 Sep 25.
Two important aspects of peptide and protein quantification by LC-MS/MS, the enzymatic digestion step and the internal standardization approach, were systematically investigated with a small protein, salmon calcitonin, which could be analyzed both without and with digestion. Quantification of undigested salmon calcitonin, after solid-phase extraction from plasma, resulted in a lower limit of quantification of 10 pg/mL, while introduction of a tryptic digestion step, followed by quantification of a signature peptide, increased this to 50 pg/mL. The sensitivity was reduced by interferences in the selected reaction monitoring (SRM) transition of the signature peptide due to the increase in sample complexity caused by the digestion and a less selective SRM transition of the signature peptide as compared to undigested salmon calcitonin. Eight internal standardization approaches were compared with respect to accuracy and precision in workflows with and without digestion. Analogue and stable-isotope-labeled (SIL) internal standards were evaluated including an in-house created (18)O-labeled peptide, a cleavable SIL peptide, and an internal standard created by differential derivatization of the signature peptide. We conclude that the best internal standard for the workflows both with and without digestion was the SIL form of the analyte, although the use of several SIL signature peptides and a differentially derivatized signature peptide also resulted in methods with performances which meet the FDA guidelines.
通过液相色谱-串联质谱法(LC-MS/MS)对肽和蛋白质进行定量分析时,有两个重要方面,即酶消化步骤和内标法,我们以一种小蛋白质——鲑鱼降钙素为研究对象进行了系统研究,该蛋白质既可以在未消化的情况下进行分析,也可以在消化后进行分析。从血浆中固相萃取后,对未消化的鲑鱼降钙素进行定量分析,得到的定量下限为10 pg/mL,而引入胰蛋白酶消化步骤,随后对一个特征肽进行定量分析,定量下限提高到了50 pg/mL。由于消化导致样品复杂性增加,以及与未消化的鲑鱼降钙素相比,特征肽的选择反应监测(SRM)转换选择性降低,特征肽的SRM转换受到干扰,导致灵敏度降低。比较了八种内标法在有消化和无消化工作流程中的准确性和精密度。评估了类似物和稳定同位素标记(SIL)内标,包括一种内部创建的(18)O标记肽、一种可裂解的SIL肽,以及通过对特征肽进行差异衍生化创建的内标。我们得出结论,对于有消化和无消化的工作流程,最佳内标是分析物的SIL形式,尽管使用几种SIL特征肽和一种差异衍生化的特征肽也能得到符合FDA指南的性能方法。